Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.308 DKK | -2.10% | -2.53% | -37.42% |
Feb. 22 | Transcript : BioPorto A/S - Special Call | |
Feb. 22 | BioPorto A/S Provides Revenue Guidance for the Full Year 2024 | CI |
Sales 2023 * | 31.1M 4.5M | Sales 2024 * | 40M 5.79M | Capitalization | 497M 71.87M |
---|---|---|---|---|---|
Net income 2023 * | -56M -8.1M | Net income 2024 * | -38M -5.5M | EV / Sales 2023 * | 16 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 12.4 x |
P/E ratio 2023 * |
-8.18
x | P/E ratio 2024 * |
-13.1
x | Employees | 33 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 89.17% |
Latest transcript on BioPorto A/S
1 day | -2.10% | ||
1 week | -2.53% | ||
Current month | -17.22% | ||
1 month | -20.15% | ||
3 months | -36.20% | ||
6 months | -18.56% | ||
Current year | -37.42% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 13-07-17 | |
Ursula Klause
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Prasad Devarajan
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John McDonough
CHM | Chairman | 65 | 21-04-28 |
Donnie Hardison
BRD | Director/Board Member | 74 | 21-04-28 |
Chief Executive Officer | 64 | 13-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 1.308 | -2.10% | 203,767 |
24-03-26 | 1.336 | +1.21% | 430,815 |
24-03-25 | 1.32 | -0.60% | 230,646 |
24-03-22 | 1.328 | +2.00% | 223,710 |
24-03-21 | 1.302 | -2.98% | 864,009 |
Delayed Quote Nasdaq Copenhagen, March 27, 2024 at 11:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.42% | 72.05M | |
-4.69% | 8.1B | |
-5.34% | 5.13B | |
+2.96% | 4.72B | |
-34.08% | 4.4B | |
-2.48% | 4.14B | |
+15.50% | 2.82B | |
+2.52% | 2.55B | |
+11.81% | 1.92B | |
-1.77% | 1.65B |